NCQA Adopts New PCMH Reporting Timelines

July 7th, 2020 | Archive

In response to COVID-19’s impact on practice operations, NCQA has extended PCMH recognition dates for many practices as well as granting some leniency on reporting quality improvement data. Practices may confirm their 2020 recognition extension status by logging into their Q-PASS portal. It is important to note that if the practices were not granted an extension by NCQA that they will be required to submit all required evidence based upon their predetermined submission due date.

For more information or to request additional accommodations, contact your NCQA accreditation survey coordinator or recognition account representative.

135 Corporate Woods, Suite 320
Rochester, New York 14623-1466

Phone: (585) 758-7823
Fax: (585) 424-1268

Website by:

This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP). An offer will only be made by means of a confidential private placement memorandum and subscription agreement.

ABI Value	Interpretation	Recommendation
Greater than 1.4	Calcification/vessel hardening	Refer to vascular specialist
1.0 - 1.4	Normal	None
0.9 - 1.0	Acceptable	None
0.8 - 0.9	Some arterial disease	Treat risk factor
0.5 - 0.8	Moderate arterial disease	Refer to vascular specialist
Less than 0.5	Severe arterial disease	Refer to vascular specialist

NCQA Adopts New PCMH Reporting Timelines

NCQA Adopts New PCMH Reporting Timelines

GENERAL COVID-19 INFORMATION